| Trial ID: | L7246 |
| Source ID: | NCT00282451
|
| Associated Drug: |
Biphasic Insulin Aspart
|
| Title: |
Effect of Biphasic Insulin Compared to Biphasic Insulin Combined With Insulin Aspart, With or Without Metformin in Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: biphasic insulin aspart|DRUG: insulin aspart
|
| Outcome Measures: |
Primary: HbA1c, At Visit 6 (14 weeks) | Secondary: Postprandial glucose concentration increments (calculated based on 7-point blood glucose profiles)
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
79
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2006-02
|
| Completion Date: |
2006-08
|
| Results First Posted: |
|
| Last Update Posted: |
2016-10-31
|
| Locations: |
Novo Nordisk Investigational Site, Aghakhan, Egypt|Novo Nordisk Investigational Site, Giza, Egypt|Novo Nordisk Investigational Site, Jeddah, 80215, Saudi Arabia|Novo Nordisk Investigational Site, Riyadh, 245, Saudi Arabia
|
| URL: |
https://clinicaltrials.gov/show/NCT00282451
|
